Adopting NGS for tumor profiling: Accessible sequencing. Flexible solutions.

| February 19, 2016

Date: Wednesday, February 24
Time: 9:00 AM (PT)

Claire Ray
Associate Product Manager
Oncology, Illumina

Next-generation sequencing (NGS) can help you avoid costly and time-consuming iterative testing while simultaneously helping to preserve precious samples. In this webinar, you will learn more about the advantages that NGS offers over traditional methods, and be introduced to the newest, cost effective solution for hematological and solid tumor profiling.

Discover the efficiencies of comprehensive tumor profiling with NGS:

• Reduce precious sample requirements.
• Minimize workflow protocols and save on turn-around-time.
• Simplify reporting with all relevant genes in one.
• Reduce costs by assessing multiple genes at once.

Explore new sample to data oncology solutions:

• Leverage an easy-to-use portfolio of targeted cancer gene panels.
• See the power and simplicity of the new MiniSeq™ Benchtop Sequencer.
• Experience automated, simplified analysis tools.

As a registrant, you will receive an email with a recording of the presentation after the event should you be unable to attend the live presentation.

For Research Use Only. Not for use in diagnostic procedures.

Tags: , , , ,

Category: Pathology News

Comments are closed.